IL2 and cranioectodermal dysplasia: The IL-2 elevation being early and prominent in the cytokine signature after injecting Nexvax2 gluten peptides in CeD patients is in keeping with the known kinetics of IL-2 secretion by memory CD4+ T cells in vivo (20).